B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Report

China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 20, 2022
  • PAGES：152
  • REPORT CODE：GMM1044126
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China B-Cell Maturation Antigen(BCMA) Targeted Therapies market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China B-Cell Maturation Antigen(BCMA) Targeted Therapies market. Detailed analysis of key players, along with key growth strategies adopted by B-Cell Maturation Antigen(BCMA) Targeted Therapies industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • firstVentury Equity

    • Transposagen Biopharmaceuticals

    • Onyx Pharmaceuticals

    • Credit Suisse Securities

    • Five Prime Therapeutics

    • Eureka Therapeutics

    • Sutro Biopharma

    • Malin Corporation

    • Dana-Farber Cancer Institute

    • Deerfield Partners

    • Juno Therapeutics

    By Type:

    • Bispecific Antibodies

    • Antibody Drug Conjugates

    • Chimeric Antigen Receptor T-Cells

    By End-User:

    • Liver Cancer

    • Respiratory Cancer

    • Brain Cancer

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies Market

    • 1.3 Market Segment by Type

    • 1.3.1 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate of Bispecific Antibodies from 2016 to 2027

    • 1.3.2 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate of Antibody Drug Conjugates from 2016 to 2027

    • 1.3.3 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate of Chimeric Antigen Receptor T-Cells from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate of Liver Cancer from 2016 to 2027

    • 1.4.2 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate of Respiratory Cancer from 2016 to 2027

    • 1.4.3 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate of Brain Cancer from 2016 to 2027

    • 1.4.4 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of B-Cell Maturation Antigen(BCMA) Targeted Therapies Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Major Types

    • 3.4.1 Market Size and Growth Rate of Bispecific Antibodies

    • 3.4.2 Market Size and Growth Rate of Antibody Drug Conjugates

    • 3.4.3 Market Size and Growth Rate of Chimeric Antigen Receptor T-Cells

    4 Segmentation of B-Cell Maturation Antigen(BCMA) Targeted Therapies Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Major End-Users

    • 4.4.1 Market Size and Growth Rate of B-Cell Maturation Antigen(BCMA) Targeted Therapies in Liver Cancer

    • 4.4.2 Market Size and Growth Rate of B-Cell Maturation Antigen(BCMA) Targeted Therapies in Respiratory Cancer

    • 4.4.3 Market Size and Growth Rate of B-Cell Maturation Antigen(BCMA) Targeted Therapies in Brain Cancer

    • 4.4.4 Market Size and Growth Rate of B-Cell Maturation Antigen(BCMA) Targeted Therapies in Others

    5 Market Analysis by Regions

    • 5.1 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Analysis by Regions

    • 5.2 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China B-Cell Maturation Antigen(BCMA) Targeted Therapies Landscape Analysis

    • 6.1 North China B-Cell Maturation Antigen(BCMA) Targeted Therapies Landscape Analysis by Major Types

    • 6.2 North China B-Cell Maturation Antigen(BCMA) Targeted Therapies Landscape Analysis by Major End-Users

    7 Central China B-Cell Maturation Antigen(BCMA) Targeted Therapies Landscape Analysis

    • 7.1 Central China B-Cell Maturation Antigen(BCMA) Targeted Therapies Landscape Analysis by Major Types

    • 7.2 Central China B-Cell Maturation Antigen(BCMA) Targeted Therapies Landscape Analysis by Major End-Users

    8 South China B-Cell Maturation Antigen(BCMA) Targeted Therapies Landscape Analysis

    • 8.1 South China B-Cell Maturation Antigen(BCMA) Targeted Therapies Landscape Analysis by Major Types

    • 8.2 South China B-Cell Maturation Antigen(BCMA) Targeted Therapies Landscape Analysis by Major End-Users

    9 East China B-Cell Maturation Antigen(BCMA) Targeted Therapies Landscape Analysis

    • 9.1 East China B-Cell Maturation Antigen(BCMA) Targeted Therapies Landscape Analysis by Major Types

    • 9.2 East China B-Cell Maturation Antigen(BCMA) Targeted Therapies Landscape Analysis by Major End-Users

    10 Northeast China B-Cell Maturation Antigen(BCMA) Targeted Therapies Landscape Analysis

    • 10.1 Northeast China B-Cell Maturation Antigen(BCMA) Targeted Therapies Landscape Analysis by Major Types

    • 10.2 Northeast China B-Cell Maturation Antigen(BCMA) Targeted Therapies Landscape Analysis by Major End-Users

    11 Southwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Landscape Analysis

    • 11.1 Southwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Landscape Analysis by Major Types

    • 11.2 Southwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Landscape Analysis by Major End-Users

    12 Northwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Landscape Analysis

    • 12.1 Northwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Landscape Analysis by Major Types

    • 12.2 Northwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 firstVentury Equity

      • 13.1.1 firstVentury Equity Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Transposagen Biopharmaceuticals

      • 13.2.1 Transposagen Biopharmaceuticals Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Onyx Pharmaceuticals

      • 13.3.1 Onyx Pharmaceuticals Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Credit Suisse Securities

      • 13.4.1 Credit Suisse Securities Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Five Prime Therapeutics

      • 13.5.1 Five Prime Therapeutics Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Eureka Therapeutics

      • 13.6.1 Eureka Therapeutics Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Sutro Biopharma

      • 13.7.1 Sutro Biopharma Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Malin Corporation

      • 13.8.1 Malin Corporation Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Dana-Farber Cancer Institute

      • 13.9.1 Dana-Farber Cancer Institute Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Deerfield Partners

      • 13.10.1 Deerfield Partners Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 Juno Therapeutics

      • 13.11.1 Juno Therapeutics Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate of Bispecific Antibodies from 2016 to 2027

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate of Antibody Drug Conjugates from 2016 to 2027

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate of Chimeric Antigen Receptor T-Cells from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate of Liver Cancer from 2016 to 2027

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate of Respiratory Cancer from 2016 to 2027

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate of Brain Cancer from 2016 to 2027

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of B-Cell Maturation Antigen(BCMA) Targeted Therapies

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Different Types from 2016 to 2027

    • Table Consumption Share of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Bispecific Antibodies

    • Figure Market Size and Growth Rate of Antibody Drug Conjugates

    • Figure Market Size and Growth Rate of Chimeric Antigen Receptor T-Cells

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Different End-Users from 2016 to 2027

    • Table Consumption Share of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Liver Cancer

    • Figure Market Size and Growth Rate of Respiratory Cancer

    • Figure Market Size and Growth Rate of Brain Cancer

    • Figure Market Size and Growth Rate of Others

    • Table China B-Cell Maturation Antigen(BCMA) Targeted Therapies Production by Regions

    • Table China B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Share by Regions

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Share by Regions in 2016

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Share by Regions in 2021

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Share by Regions in 2027

    • Table China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Regions

    • Table China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Regions

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Regions in 2016

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Regions in 2021

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Regions in 2027

    • Table North China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Types from 2016 to 2027

    • Table North China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types from 2016 to 2027

    • Figure North China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types in 2016

    • Figure North China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types in 2021

    • Figure North China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types in 2027

    • Table North China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by End-Users from 2016 to 2027

    • Table North China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users from 2016 to 2027

    • Figure North China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users in 2016

    • Figure North China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users in 2021

    • Figure North China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users in 2027

    • Table Central China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Types from 2016 to 2027

    • Table Central China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types from 2016 to 2027

    • Figure Central China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types in 2016

    • Figure Central China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types in 2021

    • Figure Central China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types in 2027

    • Table Central China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by End-Users from 2016 to 2027

    • Table Central China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users from 2016 to 2027

    • Figure Central China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users in 2016

    • Figure Central China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users in 2021

    • Figure Central China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users in 2027

    • Table South China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Types from 2016 to 2027

    • Table South China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types from 2016 to 2027

    • Figure South China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types in 2016

    • Figure South China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types in 2021

    • Figure South China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types in 2027

    • Table South China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by End-Users from 2016 to 2027

    • Table South China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users from 2016 to 2027

    • Figure South China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users in 2016

    • Figure South China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users in 2021

    • Figure South China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users in 2027

    • Table East China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Types from 2016 to 2027

    • Table East China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types from 2016 to 2027

    • Figure East China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types in 2016

    • Figure East China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types in 2021

    • Figure East China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types in 2027

    • Table East China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by End-Users from 2016 to 2027

    • Table East China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users from 2016 to 2027

    • Figure East China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users in 2016

    • Figure East China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users in 2021

    • Figure East China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users in 2027

    • Table Northeast China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Types from 2016 to 2027

    • Table Northeast China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types from 2016 to 2027

    • Figure Northeast China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types in 2016

    • Figure Northeast China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types in 2021

    • Figure Northeast China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types in 2027

    • Table Northeast China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by End-Users from 2016 to 2027

    • Table Northeast China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users in 2016

    • Figure Northeast China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users in 2021

    • Figure Northeast China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users in 2027

    • Table Southwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Types from 2016 to 2027

    • Table Southwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types from 2016 to 2027

    • Figure Southwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types in 2016

    • Figure Southwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types in 2021

    • Figure Southwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types in 2027

    • Table Southwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by End-Users from 2016 to 2027

    • Table Southwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users in 2016

    • Figure Southwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users in 2021

    • Figure Southwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users in 2027

    • Table Northwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Types from 2016 to 2027

    • Table Northwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types from 2016 to 2027

    • Figure Northwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types in 2016

    • Figure Northwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types in 2021

    • Figure Northwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by Types in 2027

    • Table Northwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by End-Users from 2016 to 2027

    • Table Northwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users in 2016

    • Figure Northwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users in 2021

    • Figure Northwest China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of firstVentury Equity

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of firstVentury Equity

    • Figure Sales and Growth Rate Analysis of firstVentury Equity

    • Figure Revenue and Market Share Analysis of firstVentury Equity

    • Table Product and Service Introduction of firstVentury Equity

    • Table Company Profile and Development Status of Transposagen Biopharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Transposagen Biopharmaceuticals

    • Figure Sales and Growth Rate Analysis of Transposagen Biopharmaceuticals

    • Figure Revenue and Market Share Analysis of Transposagen Biopharmaceuticals

    • Table Product and Service Introduction of Transposagen Biopharmaceuticals

    • Table Company Profile and Development Status of Onyx Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Onyx Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Onyx Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Onyx Pharmaceuticals

    • Table Product and Service Introduction of Onyx Pharmaceuticals

    • Table Company Profile and Development Status of Credit Suisse Securities

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Credit Suisse Securities

    • Figure Sales and Growth Rate Analysis of Credit Suisse Securities

    • Figure Revenue and Market Share Analysis of Credit Suisse Securities

    • Table Product and Service Introduction of Credit Suisse Securities

    • Table Company Profile and Development Status of Five Prime Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Five Prime Therapeutics

    • Figure Sales and Growth Rate Analysis of Five Prime Therapeutics

    • Figure Revenue and Market Share Analysis of Five Prime Therapeutics

    • Table Product and Service Introduction of Five Prime Therapeutics

    • Table Company Profile and Development Status of Eureka Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eureka Therapeutics

    • Figure Sales and Growth Rate Analysis of Eureka Therapeutics

    • Figure Revenue and Market Share Analysis of Eureka Therapeutics

    • Table Product and Service Introduction of Eureka Therapeutics

    • Table Company Profile and Development Status of Sutro Biopharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sutro Biopharma

    • Figure Sales and Growth Rate Analysis of Sutro Biopharma

    • Figure Revenue and Market Share Analysis of Sutro Biopharma

    • Table Product and Service Introduction of Sutro Biopharma

    • Table Company Profile and Development Status of Malin Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Malin Corporation

    • Figure Sales and Growth Rate Analysis of Malin Corporation

    • Figure Revenue and Market Share Analysis of Malin Corporation

    • Table Product and Service Introduction of Malin Corporation

    • Table Company Profile and Development Status of Dana-Farber Cancer Institute

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dana-Farber Cancer Institute

    • Figure Sales and Growth Rate Analysis of Dana-Farber Cancer Institute

    • Figure Revenue and Market Share Analysis of Dana-Farber Cancer Institute

    • Table Product and Service Introduction of Dana-Farber Cancer Institute

    • Table Company Profile and Development Status of Deerfield Partners

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Deerfield Partners

    • Figure Sales and Growth Rate Analysis of Deerfield Partners

    • Figure Revenue and Market Share Analysis of Deerfield Partners

    • Table Product and Service Introduction of Deerfield Partners

    • Table Company Profile and Development Status of Juno Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Juno Therapeutics

    • Figure Sales and Growth Rate Analysis of Juno Therapeutics

    • Figure Revenue and Market Share Analysis of Juno Therapeutics

    • Table Product and Service Introduction of Juno Therapeutics


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US